Ly6E on tumor cells impairs anti-tumor T-cell responses: a novel mechanism of tumor-induced immune exclusion

被引:0
作者
Lan, Hailin [1 ,2 ]
Chen, Yiting [1 ,2 ]
Yue, Wu [1 ,2 ]
Li, Lijun [1 ]
Zhang, Renlu [1 ,2 ]
Chen, Yunhan [1 ]
Zhu, Yanyang [1 ]
Zhang, Qiuyu [1 ,2 ]
机构
[1] Fujian Med Univ, Inst Immunotherapy, Fuzhou 350122, Peoples R China
[2] Fujian Med Univ, Sch Basic Med Sci, Fuzhou 350122, Peoples R China
基金
中国国家自然科学基金;
关键词
Ly6E; Breast cancer; CD8(+) T cells; Immune exclusion; Macrophage; ANTIGEN; 6; COMPLEX; THYMIC SHARED ANTIGEN-1; ANTIBODY-DRUG CONJUGATE; LOCUS E; LYMPHOCYTE; EXPRESSION; FAMILY;
D O I
10.1007/s00262-024-03851-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Lymphocyte antigen 6 complex, locus E (Ly6E) has been initially demonstrated to involve in T cell activity and impair viral infectivity. Recently, high expression levels of Ly6E have been reported in tumor microenvironment (TME) of various types of cancers. However, the immunoregulatory mechanism of Ly6E manipulating TME remains unknown. Methods TCGA database and Kaplan-Meier plotter database were used to evaluate the correlation between Ly6E expression levels and cancer patient survival. After analyzing Ly6E expression levels in human breast cancer tissues and tumor cell lines, we generated Ly6E knockout (KO) and overexpression (OE) mouse cell lines. Cell proliferation ability in vitro and the ability of growth and metastasis in mouse tumor models were compared between KO/OE and wild-type tumor cells. On day 7 after tumor implantation, tumor tissues were separated for flow cytometric assay, bulk RNA sequencing and single-cell RNA sequencing (ScRNA-seq). The role of Ly6E-expressing tumor cell on macrophage was analyzed in vitro. Results Our result surprisingly found that high Ly6E expression levels were associated with CD8(+) T cell exclusion in tumor tissues and resistance to immunotherapy. Our data showed that knockout of Ly6E in tumor cells prompts tumor regression and inhibits tumor metastases, and Ly6E-OE tumor cells vice versa. The enhanced anti-tumor effect of Ly6E knockout in tumor cells was dependent on T cell response and formed long-lasting memory. The increase in the CD8(+) T-cell infiltration into the tumor islet of Ly6E-KO tumors confirmed the role of Ly6E on T cell exclusion. ScRNA-seq analysis showed that M2 macrophages are particularly abundant in the Ly6E-expressing tumor tissues, especially M2-4 macrophage cluster identified by high levels of Arg-1, indicates that Ly6E-expressing tumor cells might restrict T cell infiltration via M2 macrophages. Moreover, in vitro assay showed that cell culture media derived from Ly6E-positive tumor cells promoted macrophage migration and M2 polarization. Conclusion Our study illuminated that Ly6E-expressing tumor cells facilitated the accumulation of M2 macrophages in TME, which contributes to CD8(+) T cell exclusion and provides new insights for improving efficacy of cancer immunotherapy.
引用
收藏
页数:16
相关论文
共 34 条
  • [21] Different Tumor Microenvironments Contain Functionally Distinct Subsets of Macrophages Derived from Ly6C(high) Monocytes
    Movahedi, Kiavash
    Laoui, Damya
    Gysemans, Conny
    Baeten, Martijn
    Stange, Geert
    Van den Bossche, Jan
    Mack, Matthias
    Pipeleers, Daniel
    Veld, Peter In't
    De Baetselier, Patrick
    Van Ginderachter, Jo A.
    [J]. CANCER RESEARCH, 2010, 70 (14) : 5728 - 5739
  • [22] Improving efficacy of cancer immunotherapy through targeting of macrophages
    Peranzoni, Elisa
    Donnadieu, Emmanuel
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (01) : 189 - 192
  • [23] Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatment
    Peranzoni, Elisa
    Lemoine, Jean
    Vimeux, Lene
    Feuillet, Vincent
    Barrin, Sarah
    Kantari-Mimoun, Chahrazade
    Bercovici, Nadage
    Guerin, Marion
    Biton, Jerome
    Ouakrim, Hanane
    Regnier, Fabienne
    Lupo, Audrey
    Alifano, Marco
    Damotte, Diane
    Donnadieu, Emmanuel
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (17) : E4041 - E4050
  • [24] Pfaender S, 2020, NAT MICROBIOL, V5, P1330, DOI [10.1038/s41564-020-0769-y, 10.1101/2020.03.05.979260]
  • [25] CD8+ T cell differentiation and dysfunction in cancer
    Philip, Mary
    Schietinger, Andrea
    [J]. NATURE REVIEWS IMMUNOLOGY, 2022, 22 (04) : 209 - 223
  • [26] SAITOH SI, 1995, J IMMUNOL, V155, P5574
  • [27] Primary Tumor Hypoxia Recruits CD11b+/Ly6Cmed/Ly6G+ Immune Suppressor Cells and Compromises NK Cell Cytotoxicity in the Premetastatic Niche
    Sceneay, Jaclyn
    Chow, Melvyn T.
    Chen, Anna
    Halse, Heloise M.
    Wong, Christina S. F.
    Andrews, Daniel M.
    Sloan, Erica K.
    Parker, Belinda S.
    Bowtell, David D.
    Smyth, Mark J.
    Moeller, Andreas
    [J]. CANCER RESEARCH, 2012, 72 (16) : 3906 - 3911
  • [28] ID1 expressing macrophages support cancer cell stemness and limit CD8+ T cell infiltration in colorectal cancer
    Shang, Shuang
    Yang, Chen
    Chen, Fei
    Xiang, Ren-shen
    Zhang, Huan
    Dai, Shu-yuan
    Liu, Jing
    Lv, Xiao-xi
    Zhang, Cheng
    Liu, Xiao-tong
    Zhang, Qi
    Lu, Shuai-bing
    Song, Jia-wei
    Yu, Jiao-jiao
    Zhou, Ji-chao
    Zhang, Xiao-wei
    Cui, Bing
    Li, Ping-ping
    Zhu, Sheng-tao
    Zhang, Hai-zeng
    Hua, Fang
    [J]. NATURE COMMUNICATIONS, 2023, 14 (01)
  • [29] Modulating the Tumor Microenvironment via Oncolytic Viruses and CSF-1R Inhibition Synergistically Enhances Anti-PD-1 Immunotherapy
    Shi, Gang
    Yang, Qianmei
    Zhang, Yujing
    Jiang, Qingyuan
    Lin, Yi
    Yang, Shenshen
    Wang, Huiling
    Cheng, Lin
    Zhang, Xin
    Li, Yimin
    Wang, Qingnan
    Liu, Yi
    Wang, Qin
    Zhang, Hantao
    Su, Xiaolan
    Dai, Lei
    Liu, Lei
    Zhang, Shuang
    Li, Jia
    Li, Zhi
    Yang, Yang
    Yu, Dechao
    Wei, Yuquan
    Deng, Hongxin
    [J]. MOLECULAR THERAPY, 2019, 27 (01) : 244 - 260
  • [30] SPANGRUDE GJ, 1988, J IMMUNOL, V141, P3697